文献速递湿疹皮炎与荨麻疹

特应性皮炎(湿疹)患者及照护者对治疗的价值观与偏好:一项系统综述

Values and Preferences of Patients and Caregivers Regarding Treatment of Atopic Dermatitis (Eczema): A Systematic Review.
PubMed 文献 · JAMA Dermatol · 2023-01-01

本系统综述检索MEDLINE、Embase、PsycINFO和CINAHL数据库至2022年3月20日,纳入62项研究(n=19 442),定性整合特应性皮炎患者及照护者对治疗的价值观与偏好。高确定性证据显示患者及照护者偏好从非药物治疗开始并随病情加重升级治疗;中等确定性证据显示治疗不良反应是重要顾虑;低确定性证据显示偏好无味、不可见且对日常生活影响最小的治疗。

要点

  • 高确定性证据:患者及照护者偏好从非药物治疗开始,随特应性皮炎严重度增加而升级治疗。
  • 中等确定性证据:治疗不良反应是患者及照护者的重要顾虑。
  • 低确定性证据:患者及照护者偏好无味、不可见且对日常生活影响最小的治疗。

核心结论

  • 本综述识别出6个关键主题,可能为最佳临床照护、实践指南和未来研究提供信息。

研究设计与样本

  • 配对评价者独立筛选MEDLINE、Embase、PsycINFO和CINAHL数据库自建库至2022年3月20日的研究,纳入特应性皮炎患者或照护者价值观与偏好的研究,共62项研究(n=19 442),研究间中位年龄15岁(范围3-44岁),59%为女性参与者。

主要发现

  • 高确定性证据显示患者及照护者偏好从非药物治疗开始,并随特应性皮炎严重度增加而升级治疗。
  • 中等确定性证据显示治疗不良反应是重要顾虑。
  • 低确定性证据显示患者及照护者偏好无味、不可见且对日常生活影响最小的治疗。
  • 患者重视能缓解瘙痒和灼热皮肤的治疗,并偏好 sparingly 使用外用糖皮质激素。
  • 患者重视牢固的患者-临床医生关系;部分研究呈现不同观点,18项研究存在行业赞助偏倚高风险。

局限性

  • 部分研究呈现不同观点。
  • 18项研究存在行业赞助偏倚高风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Patient values and preferences can inform atopic dermatitis (AD) care. Systematic summaries of evidence addressing patient values and preferences have not previously been available. OBJECTIVE: To inform American Academy of Allergy, Asthma & Immunology (AAAAI)/American College of Allergy, Asthma and Immunology (ACAAI) Joint Task Force on Practice Parameters AD guideline development, patient and caregiver values and preferences in the management of AD were systematically synthesized. EVIDENCE REVIEW: Paired reviewers independently screened MEDLINE, Embase, PsycINFO, and CINAHL databases from inception until March 20, 2022, for studies of patients with AD or their caregivers, eliciting values and preferences about treatment, rated risk of bias, and extracted data. Thematic and inductive content analysis to qualitatively synthesize the findings was used. Patients, caregivers, and clinical experts provided triangulation. The GRADE-CERQual (Grading of Recommendations Assessment, Development and Evaluation-Confidence in the Evidence from Reviews of Qualitative Research) informed rating of the quality of evidence. FINDINGS: A total of 7780 studies were identified, of which 62 proved eligible (n = 19 442; median age across studies [range], 15 years [3-44]; 59% female participants). High certainty evidence showed that patients and caregivers preferred to start with nonmedical treatments and to step up therapy with increasing AD severity. Moderate certainty evidence showed that adverse effects from treatment were a substantial concern. Low certainty evidence showed that patients and caregivers preferred odorless treatments that are not visible and have a minimal effect on daily life. Patients valued treatments capable of relieving itching and burning skin and preferred to apply topical corticosteroids sparingly. Patients valued a strong patient-clinician relationship. Some studies presented varied perspectives and 18 were at high risk for industry sponsorship bias. CONCLUSIONS AND RELEVANCE: In the first systematic review to address patient values and preferences in management of AD to our knowledge, 6 key themes that may inform optimal clinical care, practice guidelines, and future research have been identified.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Maleki-Yazdi KA, Heen AF, Zhao IX, et al. Values and Preferences of Patients and Caregivers Regarding Treatment of Atopic Dermatitis (Eczema): A Systematic Review. JAMA Dermatol. 2023. PMID: 36696136. doi:10.1001/jamadermatol.2022.6045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。